Supplementary Tables 1-2 and Supplementary Figures 1-4 from Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis

<p>Supplementary Table 1. Published estimates of the decrease in CRC screening rates as a result of the COVID-19 pandemic (March-September) identified by our literature search. Supplementary Table 2. Published estimates of the decrease in CRC diagnoses rates as a result of the COVID-19 pandemic (March-September) identified by our literature search. Some studies distinguish between new and all diagnoses. Supplementary Figure 1. Simulated screening in MISCAN: screened with any test (A), fecal immunochemical testing in the past year (FIT) (B), endoscopy in the past 5 years (C), endoscopy in the past 10 years (D), proportion of endoscopies that was colonoscopy (E), and percentage up-to-date with screening (F). Supplementary Figure 2. Simulated incidence (A-C) and mortality rates (D-F) for all three recovery periods were smoothed using a logarithmic regression model. Supplementary Figure 3. Severity of disruption in preventive (panel A) and diagnostic (panel B) services during the disruption period. Supplementary Figure 4. Cumulative excess CRC cases (A) and deaths (B) compared to a scenario without pandemic-induced delays over time for different recovery scenarios.</p>